How would you further evaluate and treat this patient? Heart failure with preserved ejection fraction is a heterogeneous syndrome. The diagnosis of the condition requires ruling out potential ...

DelveInsight's Heart failure with Reduced Ejection Fraction Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing ...

EF = ejection fraction; HF = heart failure; HR = hazard ratio; I-PRESERVE = irbesartan in heart failure with preserved systolic function; LV = left ventricular; MI = myocardial infarction ...

An ejection fraction >35% is unconventional to be considered "preserved," so the results of this trial are inconclusive on whether patients with heart failure and ejection fractions usually ...

Research led by Professor Hai-Ling Margaret Cheng (BME) opens the door to earlier treatment and better outcomes ...

AI model transforms heart failure care by precisely identifying cases and enhancing quality evaluations in clinical practice.

The following is a summary of “Unmasking High-Output Heart Failure: Beyond Conventional Paradigms,” published in the January ...

Both incident and recurrent heart failure hospitalization risk is associated with post-traumatic stress disorder among patients with CAD.